
ASCO Breakthrough
Breast Cancer Gene-Expression Signature May Help Predict Recurrence Postradiotherapy
Breast Cancer Gene-Expression Signature May Help Predict Recurrence Postradiotherapy
What we heard was a resounding sense that people want to be able to control their data,” says lead study author Reshma Jagsi, MD, DPhil , deputy chair of radiation oncology and director of the Center
Ljungman Laboratory: Early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.
The Radiation & Cancer Biology Division and Rogel Cancer Center to introduce the SARRP Image-guided micro irradiator for animal studies to the Experimental Irradiation Shared Resource (EISR) in March 2019.
First system to integrate genomic biomarkers into routine clinical risk groups
99% local control and low complication rate achieved at one year (95% at 2 yrs) with individualized radiation therapy Phase II clinical trial
To improve local tumor control in advanced nonsmall cell lung cancer, a midtreatment PET-CT scan can detect active tumors for escalated radiation, new research finds.
It should be common for clinics to have ability to rapidly assemble datasets to address practice quality improvement (PQI), routine clinical translational research (CTR) and other arising questions to aid patients in our clinics today.